ARDX Falls 3.0% After Investor Investigation Notice
Ardelyx (ARDX) fell 3.0% on Aug 13, 2026 after Levi & Korsinsky published a notice saying it’s investigating potential securities law violations involving the company.
What Ardelyx announced
The news wasn’t a new product update or a financing — it was an outside law firm’s investigation notice focused on Ardelyx and its recent disclosures. Levi & Korsinsky said it is investigating potential securities law violations on behalf of Ardelyx shareholders. The notice points back to Ardelyx’s quarterly breakdown released after the close on August 6, 2026, which included IBSRELA product revenue of $86.2 million and XPHOZAH product revenue of $31.9 million.
The notice also highlights that Ardelyx lowered its full-year 2026 IBSRELA revenue guidance to $350 million to $370 million from $410 million to $430 million, and said it is reassessing the timing of its long-term $1 billion revenue target for IBSRELA.
What it means for Ardelyx
An investigation notice like this can keep the spotlight on a company’s messaging around results and outlook — especially when it follows a revenue miss and a guidance reset. The firm’s announcement suggests it’s looking at whether shareholders were harmed by how information was communicated, which can add another layer of uncertainty for investors.
Operationally, the bigger takeaway referenced in the notice is the guidance change: lowering IBSRELA revenue expectations and reassessing the timeline for a long-term revenue target could shape how the market frames Ardelyx’s growth story. The notice also notes that analysts cut price targets following the release, reinforcing that sentiment around the outlook shifted quickly.
How the stock reacted
ARDX moved lower throughout the session.
| Window | Move |
|---|---|
| 5 min | -1.6% |
| 10 min | -1.6% |
| 30 min | -2.1% |
| 1 hour | -2.9% |
| end of day | -3.0% |
On a market-adjusted basis, ARDX underperformed the SPY by -3.4% on the day.